ES2360763T3 - Derivados de piridina para el tratamiento de desórdenes metabólicos relacionados con la resistencia a la insulina o hiperglucemia. - Google Patents

Derivados de piridina para el tratamiento de desórdenes metabólicos relacionados con la resistencia a la insulina o hiperglucemia. Download PDF

Info

Publication number
ES2360763T3
ES2360763T3 ES07826467T ES07826467T ES2360763T3 ES 2360763 T3 ES2360763 T3 ES 2360763T3 ES 07826467 T ES07826467 T ES 07826467T ES 07826467 T ES07826467 T ES 07826467T ES 2360763 T3 ES2360763 T3 ES 2360763T3
Authority
ES
Spain
Prior art keywords
compound
phenoxy
pharmaceutically acceptable
substituted
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07826467T
Other languages
English (en)
Spanish (es)
Inventor
Nabajyoti Deka
Sivaramakrishnan Hariharan
Swapnil Ramesh Bajare
Rosalind Adaikalasamy Marita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Piramal Life Sciences Ltd
Original Assignee
Piramal Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Life Sciences Ltd filed Critical Piramal Life Sciences Ltd
Application granted granted Critical
Publication of ES2360763T3 publication Critical patent/ES2360763T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
ES07826467T 2006-09-21 2007-09-20 Derivados de piridina para el tratamiento de desórdenes metabólicos relacionados con la resistencia a la insulina o hiperglucemia. Active ES2360763T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84619406P 2006-09-21 2006-09-21
US846194P 2006-09-21
US875672P 2006-12-18

Publications (1)

Publication Number Publication Date
ES2360763T3 true ES2360763T3 (es) 2011-06-08

Family

ID=41095728

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07826467T Active ES2360763T3 (es) 2006-09-21 2007-09-20 Derivados de piridina para el tratamiento de desórdenes metabólicos relacionados con la resistencia a la insulina o hiperglucemia.

Country Status (2)

Country Link
CN (2) CN101528734B (zh)
ES (1) ES2360763T3 (zh)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01013199A (es) * 1999-06-30 2003-08-20 Tularik Inc Compuestos para la modulacion de la actividad de ppary.

Also Published As

Publication number Publication date
CN101528734A (zh) 2009-09-09
CN101547902A (zh) 2009-09-30
CN101528734B (zh) 2013-02-13
CN101547902B (zh) 2012-10-31

Similar Documents

Publication Publication Date Title
AU2013358591B2 (en) Pyrimido [4,5-b]quinoline-4,5 (3H,10H)-diones as nonsense mutation suppressors
EA021672B1 (ru) Модуляторы рецепторов сфингозин-1-фосфата и их применение
US8349862B2 (en) Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia
TW202019880A (zh) 作為神經激肽－１受體拮抗劑的化合物及其用途
WO2004080943A1 (ja) シンナミルアルコール誘導体化合物およびその化合物を有効成分として含有する薬剤
RU2512547C2 (ru) Содержащее конденсированную кольцевую структуру производное и его применение в медицине
TW201625610A (zh) 萘啶二酮（ｎａｐｈｔｈｙｒｉｄｉｎｅｄｉｏｎｅ）衍生物
RU2730855C2 (ru) Кфтр регуляторы и способы их применения
ES2360763T3 (es) Derivados de piridina para el tratamiento de desórdenes metabólicos relacionados con la resistencia a la insulina o hiperglucemia.
TWI841598B (zh) 用於治療雌激素受體陽性乳癌之組合療法
TW200300681A (en) Carboxylic acid derivative compound and medicament containing same as active ingredient